Safety and Efficacy of OCL 503 in Prostate Artery Embolization
NCT02509975
·
clinicaltrials.gov ↗
NA
Phase
COMPLETED
Status
10
Enrollment
INDUSTRY
Sponsor class
Conditions
Benign Prostatic Hyperplasia
Benign Prostatic Hypertrophy
Interventions
DEVICE:
Prostate artery embolization.
Sponsor
IMBiotechnologies Ltd.